Some studies reported the tumor suppressive properties of IRF9, such as the facilitation of the antiproliferative effects of IFN in prostate cancer cells, reduced tumor growth in renal clear cell carcinoma, and effects in leukemia [29,31,41]. Here, IRF9 is linked to leukemia.